PATRONO, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 2.154
EU - Europa 1.761
AS - Asia 1.415
SA - Sud America 94
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 5.437
Nazione #
US - Stati Uniti d'America 2.134
SG - Singapore 530
CN - Cina 433
UA - Ucraina 367
IE - Irlanda 312
TR - Turchia 298
SE - Svezia 253
GB - Regno Unito 211
DE - Germania 173
FR - Francia 163
IT - Italia 101
IN - India 97
FI - Finlandia 91
BR - Brasile 82
RU - Federazione Russa 59
HK - Hong Kong 16
CA - Canada 10
BE - Belgio 7
AR - Argentina 6
IQ - Iraq 6
PL - Polonia 6
EU - Europa 5
IL - Israele 5
MX - Messico 5
CZ - Repubblica Ceca 4
IR - Iran 4
NL - Olanda 4
SA - Arabia Saudita 4
VN - Vietnam 4
AT - Austria 3
EG - Egitto 3
TW - Taiwan 3
UY - Uruguay 3
BD - Bangladesh 2
ES - Italia 2
HN - Honduras 2
KG - Kirghizistan 2
QA - Qatar 2
AU - Australia 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
ID - Indonesia 1
JO - Giordania 1
JP - Giappone 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PK - Pakistan 1
RS - Serbia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 5.437
Città #
Singapore 442
Jacksonville 411
Chandler 365
Dublin 310
Southend 172
Izmir 147
Princeton 143
Wilmington 105
Nanjing 102
Santa Clara 78
Beijing 77
Dearborn 75
Ashburn 71
Cambridge 67
Munich 44
The Dalles 42
Ann Arbor 41
Tongling 39
Nanchang 36
Woodbridge 35
Altamura 29
Shenyang 23
Kunming 21
Helsinki 19
New York 19
Boardman 18
Jiaxing 18
Los Angeles 18
Grevenbroich 17
Hebei 17
Hong Kong 16
Changsha 15
Washington 15
Augusta 13
Norwalk 13
Chieti 12
Houston 12
Moscow 12
Tianjin 12
San Mateo 10
Falls Church 9
Hangzhou 9
Orange 8
Brussels 7
Jinan 7
Lanzhou 7
Leawood 7
Chicago 6
Seattle 6
Shanghai 6
Brooklyn 5
Frankfurt am Main 5
San Francisco 5
Turku 5
Zhengzhou 5
Brno 4
Hackney 4
Hefei 4
Taiyuan 4
Tavagnacco 4
Toronto 4
Belo Horizonte 3
Boston 3
Campinas 3
Guangzhou 3
Kocaeli 3
Montevideo 3
Mountain View 3
Pescara 3
Pune 3
Roubaix 3
San Jose 3
Santos 3
Secaucus 3
São Paulo 3
Taipei 3
Tappahannock 3
Warsaw 3
Baghdad 2
Bexley 2
Bishkek 2
Bologna 2
Cairo 2
Catania 2
Changchun 2
Chaoyang 2
Charlotte 2
Clarksburg 2
Detroit 2
Doha 2
Erbil 2
Guarulhos 2
Haikou 2
Ho Chi Minh City 2
Istanbul 2
Jeddah 2
Kraków 2
Lanciano 2
Louisville 2
Lucca 2
Totale 3.347
Nome #
Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer. 134
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 123
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 122
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 113
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 110
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 110
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 106
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 105
Platelet-specific deletion of cyclooxygenase-1 ameliorates dextran sulfate sodium-induced colitis in mice. 102
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 96
Insulin resistance as a determinant of platelet activation in obese women. 95
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 93
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 93
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 89
Aspirin, platelet inhibition and cancer prevention. 89
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 89
Cyclooxygenase-2 expression and inhibition in atherothrombosis. 88
Determinants of platelet activation in Alzheimer's disease 88
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 87
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 85
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 85
Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury? 84
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 83
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 83
Role of Platelet Activation in Dementia 81
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 81
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 80
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 80
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 80
Increased thromboxane biosynthesis in essential thrombocythemia 79
Effects of nabumetone on prostanoid biosynthesis in humans. 79
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. 79
Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. 78
Mechanisms, consequences, and prevention of coronary graft failure 78
Determinants of platelet activation in human essential hypertension. 78
Soluble CD40L as an indicator of platelet Activation in Heart Failure 77
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 76
Nutraceuticals in diabetes and metabolic syndrome. 76
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 75
Insulin resistance as a determinant of platelet activation in obese women 74
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 74
Platelet activation in obese women: role of inflammation and oxidant stress. 71
Drugs, prostaglandins, and renal function. 71
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 71
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 71
Determinants of Platelet Activation in Heart Failure. 70
Antiplatelet agents in the prevention of diabetic vascular complications 70
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 69
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 69
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 68
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 68
Determinants of Platelet Activation in Heart Failure. 68
Cyclooxygenase-2 expression and inhibition in human monocytes 68
Short term Vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects. 67
Insulin resistance as a determinant of platelet activation in obese women 66
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 66
Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prosta-glandin endoperoxide synthases 65
In vivo formation of 8-isoprostaglandin F-2 alpha and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation 65
Effects of successful weight loss or pioglitazone on thromboxane-dependent platelet activation in obese women 65
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 63
Thromboxane biosynthesis in cardiovascular diseases 63
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors 62
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 62
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 60
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective 58
Increased thromboxane biosynthesis in type IIa hypercholesterolemia 55
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 55
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 53
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man 51
In vivo platelet activation in diabetes mellitus 41
null 39
Off-pump coronary artery bypass grafting: 30 years of debate 24
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 1
Totale 5.592
Categoria #
all - tutte 23.630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021456 70 1 72 1 26 100 3 4 79 70 10 20
2021/2022275 1 4 6 47 26 5 7 18 25 9 41 86
2022/2023989 81 129 80 98 89 211 57 62 125 13 19 25
2023/2024417 32 10 31 13 30 113 126 18 2 3 5 34
2024/20251.184 95 283 202 16 9 41 12 29 79 41 128 249
2025/2026128 128 0 0 0 0 0 0 0 0 0 0 0
Totale 5.592